Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

BACKGROUND & AIMS The extensive infiltration of CD8(+) T cells in the intestinal mucosa of celiac disease (CD) patients is a hallmark of the disease. We identified a gliadin peptide (pA2) that is selectively recognized by CD8(+) T cells infiltrating intestinal mucosa of HLA-A2(+) CD patients. Herein, we investigated the phenotype, the tissue localization, and the effector mechanism of cells responsive to pA2 by using the organ culture of CD intestinal mucosa. The target of pA2-mediated cytotoxicity was also investigated by using the intestinal epithelial cell lines Caco2 and HT29, A2(+) and A2(-), respectively, as target cells. METHODS Jejunal biopsy specimens from CD patients were cultured in vitro with pA2, and cellular activation was evaluated by immunohistochemistry and cytofluorimetric analysis. Cytotoxicity of pA2-specific, intestinal CD8(+) T cells was assayed by granzyme-B and interferon-gamma release and by apoptosis of target cells. RESULTS pA2 challenge of A2(+) CD mucosa increased the percentage of CD8(+)CD25(+) and of CD80(+) cells in the lamina propria, the former mainly localized beneath the epithelium, as well as the number of terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling-positive cells (TUNEL(+)) in the epithelium. Intraepithelial CD3(+) cells and enterocyte expression of Fas were also increased. CD8(+)CD25(+) and CD8(+)FASL(+) T cells were significantly increased in cell preparations from biopsy specimens cultured with pA2. CD8(+) T-cell lines released both granzyme-B and interferon-gamma following recognition of pA2 when presented by Caco2 and not by HT29. CONCLUSIONS These data indicate that gliadins contain peptides able to activate, through a TCR/HLA class I interaction, CD8-mediated response in intestinal CD mucosa and to induce the enterocyte apoptosis.

[1]  Nebojsa Jojic,et al.  Extensive HLA class I allele promiscuity among viral CTL epitopes , 2007, European journal of immunology.

[2]  O. Hernell,et al.  Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. , 2007, International immunology.

[3]  C. Gianfrani,et al.  Gliadin Regulates the NK-Dendritic Cell Cross-Talk by HLA-E Surface Stabilization1 , 2007, The Journal of Immunology.

[4]  A. Camarca,et al.  Gliadin-Specific Type 1 Regulatory T Cells from the Intestinal Mucosa of Treated Celiac Patients Inhibit Pathogenic T Cells , 2006, The Journal of Immunology.

[5]  A. Šedivá,et al.  Gliadin Fragments Induce Phenotypic and Functional Maturation of Human Dendritic Cells1 , 2005, The Journal of Immunology.

[6]  A. Yanaka,et al.  Alteration of intestinal epithelial function by intraepithelial lymphocyte homing , 2005, Journal of Gastroenterology.

[7]  C. Gianfrani,et al.  Adaptive and innate immune responses in celiac disease. , 2005, Immunology letters.

[8]  F. León,et al.  Cytokine Production by Intestinal Intraepithelial Lymphocyte Subsets in Celiac Disease , 2005, Digestive Diseases and Sciences.

[9]  O. Lund,et al.  The Immune Epitope Database and Analysis Resource: From Vision to Blueprint , 2005, PLoS biology.

[10]  C. Gianfrani,et al.  Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa , 2004, Gut.

[11]  Govind Bhagat,et al.  Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. , 2004, Immunity.

[12]  Seiamak Bahram,et al.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. , 2004, Immunity.

[13]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[14]  Vahid Asnafi,et al.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. , 2003, Gastroenterology.

[15]  A. Namane,et al.  Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. , 2003, Gastroenterology.

[16]  B. Korber,et al.  Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. , 2003, Journal of acquired immune deficiency syndromes.

[17]  A. Sette,et al.  Celiac Disease Association with CD8+ T Cell Responses: Identification of a Novel Gliadin-Derived HLA-A2-Restricted Epitope1 , 2003, The Journal of Immunology.

[18]  S Auricchio,et al.  An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients , 2003, Gut.

[19]  L. Sollid Coeliac disease: dissecting a complex inflammatory disorder , 2002, Nature Reviews Immunology.

[20]  K. Lundin,et al.  Staining of Celiac Disease-Relevant T Cells by Peptide-DQ2 Multimers1 , 2001, The Journal of Immunology.

[21]  A. Hayday,et al.  Intraepithelial lymphocytes: exploring the Third Way in immunology , 2001, Nature Immunology.

[22]  G. Corazza,et al.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease , 2001, Gut.

[23]  V. Raia,et al.  FAS engagement drives apoptosis of enterocytes of coeliac patients , 2001, Gut.

[24]  L. Maiuri,et al.  Interleukin 15 mediates epithelial changes in celiac disease. , 2000, Gastroenterology.

[25]  C. Doglioni,et al.  Cytolytic mechanisms of intraepithelial lymphocytes in coeliac disease (CoD) , 2000, Clinical and experimental immunology.

[26]  R. Jian,et al.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease☆☆☆ , 2000, Gastroenterology.

[27]  R. Hershberg,et al.  Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. , 2000, Immunology today.

[28]  T. Ley,et al.  How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.

[29]  K. Lundin,et al.  Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. , 1998, Gastroenterology.

[30]  F. Koning,et al.  Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A Sette,et al.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.

[32]  P. Parham,et al.  The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C , 1996, The Journal of experimental medicine.

[33]  M. Mazzilli,et al.  Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. , 1996, Gastroenterology.

[34]  Stolte,et al.  Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. , 1996, The American journal of pathology.

[35]  T. Halstensen,et al.  Gluten Stimulation of Coeliac Mucosa In Vitro Induces Activation (CD25) of Lamina Propria CD4H T cells and Macrophages but no Crypt‐Cell Hyperplasia , 1993, Scandinavian journal of immunology.

[36]  E. Thorsby,et al.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients , 1993, The Journal of experimental medicine.

[37]  L. Greco,et al.  Majority of Gliadin-Specific T-Cell Clones from Celiac Small Intestinal Mucosa Produce Interferon-γ and Interleukin-4 , 2004, Digestive Diseases and Sciences.